Teva prevails in migraine patent dispute; shares up 9%
https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-shares-up-9?source=feed_sector_healthcare
Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
0
3 Ridiculously Cheap Buffett Stocks to Buy Now
https://www.fool.com/investing/2020/03/31/3-ridiculously-cheap-buffett-stocks-to-buy-now.aspx?source=iedfolrf0000001
Mar 31, 2020 - It's been a while since the Oracle of Omaha had bargains like this in his portfolio.
0
FDA Authorizes Use of Old Malaria Drugs to Treat COVID-19
https://www.fool.com/investing/2020/03/30/fda-authorizes-use-of-old-malaria-drugs-to-treat-c.aspx?source=iedfolrf0000001
Mar 30, 2020 - Despite scant clinical evidence that they work, the FDA issued its first emergency use authorization for therapeutic products to treat the novel coronavirus.
0
Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma
http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181
Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know
http://www.zacks.com/stock/news/837115/teva-pharmaceutical-industries-ltd-teva-gains-but-lags-market-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-837115
Mar 26, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $7.90, moving +0.77% from the previous trading session.
0
Teva Pharmaceuticals Near 20-Year Lows
https://seekingalpha.com/article/4332825-teva-pharmaceuticals-near-20-year-lows?source=feed_tag_israel
Mar 18, 2020 -
0
Pages: 12
<Page 2